Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

US STOCKS-Futures fall as Trump, Hong Kong weaken mood

Published 11/11/2019, 08:57 PM
Updated 11/11/2019, 09:00 PM
US STOCKS-Futures fall as Trump, Hong Kong weaken mood
INTC
-
CSCO
-
QCOM
-
MU
-
AMD
-
SPWR
-
LPCN
-

(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window.)
* Futures down: Dow 0.41%, S&P 0.37%, Nasdaq 0.43%

By Arjun Panchadar
Nov 11 (Reuters) - U.S. stock index futures fell on Monday
as President Donald Trump's comments dampened expectations
around a U.S.-China trade deal, while escalating violence in
Hong Kong added to investor worries.
Hopes of a "phase one" deal to end the damaging 16-month
trade war and largely upbeat corporate earnings have sparked a
rally that helped the three major stock indexes close at record
highs on Friday.
But Trump said on Saturday that the United States would only
make a deal if it was the "right deal" for America, adding that
the talks had moved more slowly than he would have liked.
Trade-sensitive stocks Caterpillar Inc CAT.N Advanced
Micro Devices Inc AMD.O , Micron Technology MU.O and Intel
Corp INTC.O shed between 0.8% and 1.3% in premarket trading.
With the third-quarter earnings season drawing to a close,
attention will now be on economic data, as well as comments from
Federal Reserve Chair Jerome Powell later this week.
At 7:34 a.m. ET, Dow e-minis 1YMcv1 were down 113 points,
or 0.41%. S&P 500 e-minis EScv1 were down 11.5 points, or
0.37% and Nasdaq 100 e-minis NQcv1 were down 35.5 points, or
0.43%.
Continuing violence in Hong Kong also hit sentiment after
police shot and wounded a protester in the 24th straight week of
pro-democracy protests in the Chinese-ruled territory.
Qualcomm Inc QCOM.O fell 1.8% after Morgan Stanley
downgraded the chipmaker to "equal-weight" from "overweight".
Cisco Systems Inc CSCO.O dropped 1.3% as Piper Jaffray cut
its rating on the networking equipment maker to "neutral" from
"overweight".
SunPower Corp SPWR.O gained 3.8% after the solar cell and
panel maker said it would split into two separate
publicly-traded companies.
Lipocine Inc LPCN.O slumped 67% after the U.S. Food and
Drug Administration declined to approve its oral drug to treat a
condition that results in lower production of sex hormone.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.